image
Healthcare - Biotechnology - NASDAQ - CA
$ 1.72
-2.27 %
$ 76.3 M
Market Cap
-2.77
P/E
BALANCE SHEET
149 M ASSETS
-12.02%
3.5 M LIABILITIES
46.42%
146 M EQUITY
-12.86%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition ESSA Pharma Inc.
image
Current Assets 149 M
Cash & Short-Term Investments 148 M
Receivables 135 K
Other Current Assets 585 K
Non-Current Assets 325 K
Long-Term Investments 0
PP&E 68 K
Other Non-Current Assets 257 K
Current Liabilities 3.5 M
Accounts Payable 2.03 M
Short-Term Debt 80.3 K
Other Current Liabilities 1.39 M
Non-Current Liabilities 0
Long-Term Debt 0
Other Non-Current Liabilities 0

Balance Sheet

Millions
Sep-2023 Sep-2022 Sep-2021 Sep-2020 Sep-2019 Sep-2018 Sep-2017 Sep-2016 Sep-2015 Sep-2014 Sep-2013 Dec-2012
ASSETS
Cash & Cash Equivalents 33.7 57.1 137.8 56.3 53.3 14.8 4.0 9.0 1.6 3.7 0.2 824
Short Term Investments 114.4 110.2 57.1 22.0 0 0 0 0 0 0 0 0
Receivables 0.1 6.21 K 0.5 0.3 0.4 0.3 29.5 K 15.9 K 3.8 0 0 0
Inventory 0 110.6 0 (0.3) (0.4) 0.4 29.5 K 15.9 K 0 0 0 0
Other Current Assets 0.6 1.8 2.2 1.7 0.5 0.5 1.1 1.0 1.7 62.4 K 15 K 165
Total Current Assets 148.8 169.5 197.6 80.6 54.8 16.0 5.6 10.4 7.0 3.8 0.2 989
PP&E 68 K 0.2 0.3 55.2 K 0 0 99.9 K 0.1 0.2 14.1 K 0 0
Intangible Assets 0 0 0 0 0.2 0.2 0.2 0.3 0.3 0.4 0.4 450
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 0.3 0.3 0.3 0 (0.2) 0.2 0.2 0 0 0 0 450
Other Assets 0 (0.4) 0 55.2 K (0.2) (0.4) (0.5) (0.4) 1 0 1 0
Total Assets 149.1 169.5 198.2 80.6 54.8 16.0 5.6 10.4 7.5 4.2 0.7 1.44 K
LIABILITIES
Accounts Payable 2.0 1.0 1.4 0.7 1.1 0.5 1.3 3.5 2.0 0.6 0.2 132
Short Term Debt 80.3 K 0.1 0.1 59.1 K 3.7 2.8 2.0 0 0 0 0 0
Other Current Liabilities 1.4 36.4 39.2 24.2 0.5 0 0.1 0 11.6 21.7 K 2.44 K 1.16
Total Current Liabilities 3.5 2.3 3.9 1.2 5.6 3.3 3.8 3.6 3.1 2.2 0.2 133
Long Term Debt 0 76.4 K 0.2 0 0 3.5 5.9 0 0 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 0 183 20.4 K 0.1 18 K 19.6 K 0.2 7.3 0 0 0 0
Total Liabilities 3.5 2.4 4.2 1.3 5.6 6.9 9.9 10.9 3.1 2.2 0.2 133
EQUITY
Common Stock 278.2 278.1 277.4 131.1 76.2 40.2 26.0 26.0 19.4 4.2 4.1 4.25 K
Retained Earnings (179.5) (152.9) (117.8) (81.0) (54.8) (44.4) (33.0) (28.2) (13.1) (5.9) (4.1) 3.12 K
Other Accumulative Comprehensive Income/Loss (2.1) (2.1) (2.1) (2.1) 27.8 13.3 2.5 1.7 1.2 0.9 0.4 0
Total Equity 145.6 167.1 194.0 79.2 49.2 9.2 (4.3) (0.5) 4.4 2.0 0.5 1.31 K
Total Liabilities and Equity 149.1 169.5 198.2 80.6 54.8 16.0 5.6 10.4 7.5 4.2 0.7 0
SHARES OUTSTANDING
Common Shares Outstanding 44.1 44.0 38.5 22.4 8.4 4.6 1.5 1.3 0.9 0.8 0.8 732